5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | NEUTRAL | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.16▼ | 3.16▼ | 3.16▼ | 3.12▼ | 2.94▲ |
MA10 | 3.19▼ | 3.19▼ | 3.19▼ | 3.07▲ | 2.75▲ |
MA20 | 3.19▼ | 3.12▼ | 3.10▲ | 2.92▲ | 2.39▲ |
MA50 | 3.13▼ | 3.01▲ | 2.99▲ | 2.69▲ | 18.09▼ |
MA100 | 2.98▲ | 2.91▲ | 2.88▲ | 2.28▲ | 70.70▼ |
MA200 | 2.95▲ | 2.76▲ | 2.75▲ | 9.38▼ | 321.97▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.014▼ | -0.011▼ | -0.008▼ | 0.017▲ | 1.714▲ |
RSI | 43.299▼ | 50.407▲ | 52.302▲ | 57.224▲ | 32.163▼ |
STOCH | 1.906▼ | 29.644 | 49.708 | 59.089 | 69.692 |
WILL %R | -100.000▼ | -61.702 | -52.727 | -40.845 | -20.001▲ |
CCI | -173.602▼ | -92.199 | -35.136 | 64.871 | 130.597▲ |
MA | $EVAX Price Crossed Below MA(7) | Set Alert |
Friday, February 14, 2025 05:11 AM
Evaxion confirms Nasdaq compliance, extends cash runway to mid-2026, and anticipates EIB loan conversion in Q1 2025. Quiver AI Summary Evaxion Biotech A/S has confirmed compliance with Nasdaq's ...
|
Tuesday, January 14, 2025 01:13 PM
COPENHAGEN, Denmark, January 14, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology ...
|
Wednesday, September 25, 2024 09:07 PM
The company announced that it has entered into an option and license agreement with MSD (which is the tradename of Merck & Co., Inc., Rahway, NJ) (NYSE:MRK) for two preclinical vaccine candidates ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/08/25 | 3.18 | 3.19 | 3.05 | 3.11 | 35,560 |
25/08/25 | 3.20 | 3.25 | 3.15 | 3.206 | 55,387 |
22/08/25 | 3.15 | 3.29 | 3.10 | 3.25 | 74,198 |
21/08/25 | 3.05 | 3.15 | 2.94 | 3.1012 | 56,604 |
20/08/25 | 3.00 | 3.092 | 2.91 | 2.95 | 142,756 |
19/08/25 | 3.20 | 3.40 | 2.96 | 3.04 | 106,967 |
18/08/25 | 2.95 | 3.23 | 2.90 | 3.22 | 356,583 |
15/08/25 | 2.86 | 2.94 | 2.811 | 2.88 | 28,284 |
14/08/25 | 3.01 | 3.01 | 2.69 | 2.86 | 98,300 |
13/08/25 | 2.84 | 3.05 | 2.83 | 3.04 | 75,724 |
|
|
||||
|
|
||||
|
|